English
Home > Products > CAS NO 176317-02-5

China CAS NO 176317-02-5 Factory

We always believe that one's character decides products' quality, the details decides products' quality ,with the REALISTIC,EFFICIENT AND INNOVATIVE team spirit for CAS NO 176317-02-5,176317-02-5,2,3,4-Trifluorobromobenzene, Should you pursuit the Hi-quality, Hi-stable, Aggressive price tag parts, business name is your most effective choice!
CAS NO 176317-02-5, Our company is working by the operation principle of "integrity-based, cooperation created, people oriented, win-win cooperation". We hope we can have a friendly relationship with businessman from all over the world.

Related Products

Hot Products

  • 2-Hydroxy-5-bromopyridine

    2-Hydroxy-5-bromopyridine

    Product Name:2-Hydroxy-5-bromopyridine
    Molecular Formula:C5H4BrNO
    Molecular Weight:174
    CAS Registry Number:13466-38-1
  • 2,5-Difluorobenzyl alcohol

    2,5-Difluorobenzyl alcohol

    Product Name:2,5-Difluorobenzyl alcohol
    Molecular Formula:C7H6F2O
    Molecular Weight:144.12
    CAS Registry Number:75853-20-2
  • 4-Fluorobenzyl alcohol

    4-Fluorobenzyl alcohol

    Product Name:4-Fluorobenzyl alcohol
    Molecular Formula:C7H7FO
    Molecular Weight:126.13
    CAS Registry Number:459-56-3
  • Lovastatin

    Lovastatin

    Product Name:Lovastatin
    Molecular Formula:C24H36O5
    Molecular Weight;404.54
    CAS Registry Number;75330-75-5
  • 9-Bromoanthracene

    9-Bromoanthracene

    Product Name:9-Bromoanthracene
    Molecular Formula:C14H9Br
    Molecular Weight:257.13
    CAS Registry Number:1564-64-3
  • Linagliptin

    Linagliptin

    Product Name:Linagliptin
    Molecular Formula:C25H28N8O2
    Molecular Weight;472.54
    CAS Registry Number;668270-12-0
  • Related Blog
  • Reviews

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept